There is much evidence to suggest that potentially immunogenic tumour cells can escape cytolytic immune destruction by loss of class I antigen expression. Many tumours are allele-specific class I negative and, in murine systems, reconstitution of class I expression by gene transfection leads to an increase in tumour immunogenicity. In many systems where mice have rejected class I transfected tumour cells they are also immune to a subsequent challenge with the untransfected parent tumour. In this study we have examined the effect of stable class II antigen expression (induced by gene transfection) on a class I loss mutant (H-2Kk negative) murine cell line, K36.16. We show that H-2Ek expression is more effective at increasing tumour immunogen...
The ability of mice to mount a cytotoxic T-lymphocyte (CTL) immune response to SV40 T-antigen is det...
CD2Kb transgenic mice express the major histocompatibility complex class I (MHC I) gene, H-2Kb, unde...
Tumor cell variants were derived from the BW5147 T-cell lymphoma that differ in major histocompatibi...
We have previously found that an increased tumorigenicity and spontaneous metastatic potential of BW...
n several murine tumour systems, expression of class II major histocompatibility complex (MHC) antig...
In several murine tumour systems, expression of class II major histocompatibility complex (MHC) anti...
This study involved the conversion of class II MHC negative tumour cells, via transduction with the ...
Breaking the state of immunological unresponsiveness of tumor-bearing individuals to cancer is a pre...
Cellular cytotoxicity experiments were done to test the potential of the extra H-2 antigenic specifi...
A role for antigen stimulation in lymphoid neoplasia has been postulated and is supported by indirec...
This study was aimed at creating a more effective tumor cell vaccine by suppressing Ii protein in th...
Tumor specific immunity is mediated by cytotoxic T lymphocytes (CTL) that recognize peptide antigen ...
In vivo inoculation of a low metastatic BW 5147 derived T-cell lymphoma variant into syngeneic mice,...
Tumor specific immunity is mediated by cytotoxic T lymphocytes (CTL) that recognize peptide antigen ...
Objectives: The loss of major histocompatibility complex (MHC) classes I and II is a well-known mech...
The ability of mice to mount a cytotoxic T-lymphocyte (CTL) immune response to SV40 T-antigen is det...
CD2Kb transgenic mice express the major histocompatibility complex class I (MHC I) gene, H-2Kb, unde...
Tumor cell variants were derived from the BW5147 T-cell lymphoma that differ in major histocompatibi...
We have previously found that an increased tumorigenicity and spontaneous metastatic potential of BW...
n several murine tumour systems, expression of class II major histocompatibility complex (MHC) antig...
In several murine tumour systems, expression of class II major histocompatibility complex (MHC) anti...
This study involved the conversion of class II MHC negative tumour cells, via transduction with the ...
Breaking the state of immunological unresponsiveness of tumor-bearing individuals to cancer is a pre...
Cellular cytotoxicity experiments were done to test the potential of the extra H-2 antigenic specifi...
A role for antigen stimulation in lymphoid neoplasia has been postulated and is supported by indirec...
This study was aimed at creating a more effective tumor cell vaccine by suppressing Ii protein in th...
Tumor specific immunity is mediated by cytotoxic T lymphocytes (CTL) that recognize peptide antigen ...
In vivo inoculation of a low metastatic BW 5147 derived T-cell lymphoma variant into syngeneic mice,...
Tumor specific immunity is mediated by cytotoxic T lymphocytes (CTL) that recognize peptide antigen ...
Objectives: The loss of major histocompatibility complex (MHC) classes I and II is a well-known mech...
The ability of mice to mount a cytotoxic T-lymphocyte (CTL) immune response to SV40 T-antigen is det...
CD2Kb transgenic mice express the major histocompatibility complex class I (MHC I) gene, H-2Kb, unde...
Tumor cell variants were derived from the BW5147 T-cell lymphoma that differ in major histocompatibi...